ArticleCancer immunology research2025

Discovery of BMS-986408, a First-In-Class Dual DGKα and DGKζ Inhibitor that Unleashes PD-1 Checkpoint and CAR T-cell Immunotherapies.

Michael Wichroski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.